NET
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients (NCT01262235) | Arbutus Biopharma Corporation | 2010-12-01 |
Track NET automatically
Every clearance here is in the API, with alerts when new ones post.